Table 3 Series of patients with recurrent gliomas treated with hypofractionated stereotactic radiotherapy (H-FSRT).
From: Radiotherapeutic alternatives for previously irradiated recurrent gliomas
Author | Pt. Number | Histology | Tumor size (ml; median) | Median Dose (Gy) | Median Fraction Size (Gy) | Median survival (months) | Rate of Severe Toxiticy/Reoperation rate (%) |
|---|---|---|---|---|---|---|---|
Ernst-Stecken et al., 2006 | 15 | GBM | 22.4 | 35 | 7 | - | 0% |
Hudes et al., 1999 | 19 (1) | GBM (AA) | 12.6 | 30 | 3 | 10.5 | 0% |
Laing et al., 1993 | 22 | GBM | - | 30–50 (range) | 5–6 (range) | - | - |
Selch et al., 2000 | 15 (3;3) | GBM (AA/LGG) | 12 | 25 | 4–6 (range) | 6.7 | 0% |
Shepherd et al., 1997 | 29 (7) | GBM/AA (LGG) | 24 | 20–50 (range) | 5 | 11 (GBM/AA) | 36% |
Vordermark et al., 2005 | 10 (19) | II or III | 15 | 30 | 5 | 13.5 | 26% |
Vordermark et al., 2005 | 9 (19) | IV | 15 | 30 | 5 | 7.4 | Â |